India

Dr. Reddy's Laboratories

Offering a portfolio of products & services including APIs, CMO services, generics, biosimilars & differentiated formulations.

INDIA India

Contact Supplier

Virtual Booth

CPhI North America 2021

Attending

Request a Meeting Now

Dr. Reddy's and RDIF Commence Clinical Trials for Sputnik V Vaccine in India

Lead Product(s): Gam-COVID-Vac

Therapeutic Area: Infections and Infectious Diseases Product Name: Sputnik V

Highest Development Status: Phase II/ Phase III Product Type: Vaccine

Partner/Sponsor/Collaborator: Russian Direct Investment Fund

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable December 01, 2020

Details:

After obtaining the requisite clearance from the Central Drugs Laboratory, Dr. Reddy's Laboratories and RDIF have begun adaptive phase 2/3 clinical trials for the Sputnik V vaccine in India. The trial is a multicenter and randomised controlled safety and immunogenicity study.

Wockhardt Limited

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

INDIA India

Post An Enquiry

Virtual Booth

CPhI North America Online

Participation Not Confirmed

Update your events

Wockhardt snags Covid-19 Vaccine Manufacturing Deal From the UK Govt

Lead Product(s): ChAdOx1 nCoV-19

Therapeutic Area: Infections and Infectious Diseases Product Name: AZD1222

Highest Development Status: Phase II/ Phase III Product Type: Vaccine

Partner/Sponsor/Collaborator: UK Government

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Agreement August 03, 2020

Details:

Wockhardt has reserved manufacturing capacity to allow for the supply of multiple vaccines to the UK Government in its fight against COVID19, including AZD1222, the vaccine co-invented by the University of Oxford and its spinout company, Vaccitech and licensed by AstraZeneca.